Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | CAR-T for ALL: the impact of bridging therapy

Karlo Perica • 1 Jun 2019
ASCO 2019
Acute Lymphoblastic Leukemia

Karlo Perica, MD, PhD, of the Memorial Sloan Kettering Cancer Center, New York, NY, discusses the impact of bridging strategies in patients with R/R acute lymphoblastic leukemia (ALL) at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Karlo Perica

The future of in vivo CAR T-cell therapy
1:30
The future of in vivo CAR T-cell therapy
Karlo Perica • 24 Oct 2025
How off-the-shelf cellular therapies may change the treatment landscape in myeloma
1:28
How off-the-shelf cellular therapies may change the treatment landscape in myeloma
Karlo Perica • 24 Oct 2025
Off-the-shelf cellular therapy approaches in myeloma: allo and in vivo CARs
1:29
Off-the-shelf cellular therapy approaches in myeloma: allo and in vivo CARs
Karlo Perica • 24 Oct 2025
Investigating the efficacy of allogeneic and in vivo CAR T-cell therapies in myeloma
1:51
Investigating the efficacy of allogeneic and in vivo CAR T-cell therapies in myeloma
Karlo Perica • 24 Oct 2025

Related Videos

Advances in precision-engineered T-cell immunotherapy for alloSCT in AML, ALL and MDS
10:54
Advances in precision-engineered T-cell immunotherapy for alloSCT in AML, ALL and MDS
Samer Srour • 19 Sep 2026
New horizons in Ph+ ALL: the evolving role of bispecific antibodies
1:20
New horizons in Ph+ ALL: the evolving role of bispecific antibodies
Josep-Maria Ribera • 14 Sep 2026
NGS-MRD assessment and targeted treatment selection in ALL
1:48
NGS-MRD assessment and targeted treatment selection in ALL
Josep-Maria Ribera • 14 Sep 2026
Avoiding common pitfalls when managing patients with ALL outside of specialist centers
3:52
Avoiding common pitfalls when managing patients with ALL outside of specialist centers
Bijal Shah • 10 Sep 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals